2 ‘outstanding’ small-cap ASX shares that could explode: expert

Ask A Fund Manager: Alto Capital’s Tony Locantro reveals a pair of small caps that he reckons have a bright future.

| More on:
A group of three scientists talking excitedly while working in a lab on a diabetes test developed by Proteomics International Laboratories which is an ASX share tipped to explode by Alto Capital

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Ask A Fund Manager

The Motley Fool chats with the best in the industry so that you can get an insight into how the professionals think. In this edition, Alto Capital investment advisor Tony Locantro discusses two ASX shares that are ready to break out.

Hottest ASX shares

The Motley Fool: What are the two best stock buys right now?

Tony Locantro: Proteomics International Laboratories Ltd (ASX: PIQ), they’re in the mid-eighties [cents]. They have developed the PromarkerD test which can pick up a diabetic kidney disease before it happens, well in advance. The science is proven. 

They just need to roll that out, [and] look at reimbursements. They’ve been able to manufacture 50,000 components to get that test out. 

They’ve announced some licensing of an esophageal cancer test as well. They’re working on that. And recently, they came out with some positive biomarkers for endometriosis, which affects one in nine women, and this could lead to the world’s first non-invasive test because it does take years to diagnose.

The company has some laboratory services which it provides, and the revenue matches the cash burn but you think that their expenditure will increase. The market cap is undemanding at around $85 million. Solid management that owns a lot of the company and I think it has outstanding growth. 

It’s an outstanding growth opportunity in the biotech sector. 

The second stock I’m buying is a company called Maronan Metals Limited (ASX: MMA). I should disclose that I was heavily involved in the initial public offering (IPO) at 20 cents. The stock is now trading at 34 cents.

So, they’re about to drill at the Maronan lead, silver and copper gold resource in the Cloncurry region of North Queensland. It is already a sizable resource that requires deeper drilling to expand on the 30 million tonnes at 6.5% lead. That includes a hundred million ounces of silver. They also have a separate copper gold resource that’s around 11 million tonnes for 300,000 ounces of gold and some copper.

It’s in that vicinity of other major mines, and it could be part of a consolidation play in North Queensland. And the company’s capped around $50 million and has recently raised $15 million in its IPO. 

Again, we have extensive holdings, but it’s one of these companies that has an existing resource. The grades do get better with depth, so they’re trying to basically drill and increase the resource. There was a mining study completed in 2016, which showed favourable mining optics. 

So, highly speculative, but those are my two best buys on the market at the moment.

MF: With these minerals companies, are you ever worried about the cyclical nature of commodity prices?

TL: No.

MF: Because they’re mainly exploratory companies that you’re looking at?

TL: Yeah. 

At the moment, a lot of these mining companies are being hit with COVID issues. They’ve been hit with cost blowouts. A lot of the gold producers are now having to add dollars to their all-in sustaining cost. 

But my theory is that a good resource will override any commodity price or cycle. And even though they’re higher risk, you’re still in that exploration phase where you’ve got to move through DFS [definitive feasibility studies] really to get towards production.

So a big resource, I think it’s going to be valued, and it should be noted that around 80% of the mines in Australia are discoveries made around 1980 or [before] that, so there hasn’t been a lot of major discoveries and those that are made are rewarded with good re-ratings.

Motley Fool contributor Tony Yoo has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Ask a Fund Manager

one hundred dollar notes planted in the ground representing growth asx shares
Small Cap Shares

‘Richest pipeline’ in ASX: Expert names 3 small-cap shares to buy

Ask A Fund Manager: Alto Capital's Tony Locantro also reveals what his biggest regret in investing is.

Read more »

Stock market, ASX, investing
Ask a Fund Manager

From chasing criminals to ASX gems, why this ex-cop keeps buying in a bear market

Ask A Fund Manager: Alto Capital's Tony Locantro tells how he deals with turbulent times for stocks, like this year.

Read more »

A doctor and an elderly couple sit at a desk and look at a lung scan uploaded using Alcidion software as the Alcidion share price falls
Ask a Fund Manager

Buy and hold this ‘incredibly undervalued’ ASX share for 4 years: fundie

Ask A Fund Manager: Cyan Investment Management's Dean Fergie is confused as to why this medical software business has been…

Read more »

A couple hang off their car looking at the sun rising over the horizon.
Ask a Fund Manager

‘Great long-term investment’: Expert names small-cap ASX share to buy for cheap

Ask A Fund Manager: Cyan Investment Management's Dean Fergie gives his thoughts on three stocks that have halved in price…

Read more »

Dean Fergie, Cyan Investment Management fund manager
Ask a Fund Manager

‘Extraordinarily cheap’: The ASX share where 77% of its value is cash

Ask A Fund Manager: Cyan Investment Management's Dean Fergie reveals two shares that are absolute bargains at the moment.

Read more »

Dean Fergie, Cyan Investment Management fund manager
Ask a Fund Manager

Why this is the best time to buy small-cap ASX shares: fund manager

Ask A Fund Manager: Cyan Investment Management's Dean Fergie tells how smaller companies have plunged in value this year but…

Read more »

a man holds a plunger while also holding his arms aloft in a pose to show off his muscles and strength with a wry smile on his face.
Ask a Fund Manager

What I’d do with 3 ASX shares that have plunged this year: expert

Ask A Fund Manager: Redpoint's Max Cappetta names a 105-year-old 'green' company with excellent 21st century prospects.

Read more »

Redpoint chief executive Max Cappetta discusses three ASX shares to buy right now
Ask a Fund Manager

‘Pretty attractive’: Expert reveals 3 ASX shares to buy right now

Ask A Fund Manager: Redpoint's Max Cappetta picks one industrial, one retail and one technology stock to sink your teeth…

Read more »